SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Syndax Pharmaceuticals Q1 EPS $(0.560) Misses $(0.510) Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.560) per share which missed the analyst consensus estimate of $(0.510) by 9.8 percent. This is a 5.66 percent decrease over losses of $(0.530) per

Benzinga · 05/07/2020 20:19

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.560) per share which missed the analyst consensus estimate of $(0.510) by 9.8 percent. This is a 5.66 percent decrease over losses of $(0.530) per share from the same period last year.